NCT02719158View on ClinicalTrials.gov

Dose Ranging Study of OTO-201 in AOMT

PHASE2CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

July 31, 2016

Conditions
Acute Otitis MediaAOMT
Interventions
DRUG

6 mg ciprofloxacin

Single administration of OTO-201

DRUG

12 mg ciprofloxacin

Single administration of OTO-201

OTHER

Sham

Trial Locations (1)

92121

Contact Otonomy call center for trial locations, San Diego

Sponsors

Lead Sponsor

Otonomy, Inc.
All Listed Sponsors
lead

Otonomy, Inc.

INDUSTRY